Opus Genetics IRD Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's convertible preferred stock authorized shares?
- Opus Genetics (IRD) reported convertible preferred stock authorized shares of 2.6M in Q1 2026.
- How has Opus Genetics's convertible preferred stock authorized shares changed year-over-year?
- Opus Genetics's convertible preferred stock authorized shares decreased by 73.7% year-over-year, from 10M to 2.6M.
- What is the long-term trend for Opus Genetics's convertible preferred stock authorized shares?
- Over 5 years (2020 to 2025), Opus Genetics's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 10M to 10M.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.